— · Financial Statements
Valion Bio, Inc. (VBIO) Financial Statements
$2.14
—: VBIO
Market Cap $8.86M
Overview Financials Dividend Valion Bio, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-4.0M $-5.0M $-4.0M $-2.0M Net Profit $-5.0M $-4.0M $-20.0M $-4.0M $-1.0M EPS $-0.38 $-0.19 $-0.61 $-0.09 $-0.02 Op Margin -2125.1% -4292.9% — — —
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $1.0M $1.0M $6.0M $3.0M $1.0M Total Liabilities $1.0M $0 $1.0M $1.0M $0 Cash $1.0M $1.0M $6.0M $2.0M $1.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-1.0M $-3.0M $-4.0M $-4.0M $-2.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $2.0M $2.0M $9.0M $0 $0 Net Cash Flow $1.0M $0 $5.0M $-4.0M $-2.0M Free Cash Flow $-1.0M $-3.0M $-4.0M $-4.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.64 FCF Yield -136.80% Quick Ratio 0.86 Interest Coverage -12.33 Return 1Y -88.47% Return 3Y -99.58% Return 5Y —
Screens featuring this stock